Soleno Therapeutics (SLNO) Stock Gains Traction With Recent Regulatory Approvals
Soleno Therapeutics, Inc. (NASDAQ: SLNO) stock is witnessing a remarkable surge of 19.95% in its shares, trading at $45.45 as of the last check during current market. This noteworthy upswing of SLNO stock on the US charts is directly attributable to regulatory greenlights. Today, Soleno Therapeutics (SLNO) announced that diazoxide choline has been designated as […]
Soleno Therapeutics (SLNO) Stock Gains Traction With Recent Regulatory Approvals Read More »